Canada / Top 10 Pharma Companies 2020 Ranking
The Top 10 companies in the Canadian pharma market for 2020, ranked by revenues in USD billions. J&J takes the…
AMERICAS
USA / FDA Drug Approvals 2020
In 2020, the US FDA’s Center for Drug Evaluation & Research (CDER) approved 53 novel drugs, up from 48 in…
USA / Securing the Conditions to Secure Our Meds
The AAM’s Dan Leonard highlights the savings impact that generic and biosimilar have on US healthcare today and…
US Generics & Biosimilars / Five Takeaways from Access! 2021
Dan Leonard of the Association for Accessible Medicines (AAM) highlights five key takeaways from the…
Moderna / Bullish Bancel “Not Losing Sleep” over COVID-19 Vaccine IP Waiver, Looking to mRNA’s Future in Rare Diseases & Oncology
The day the Biden administration announced its support for the waiver of IP rights for COVID-19 vaccines,…
USA / Navigating Increasingly Stormy Market Access Waters
Certara’s Ulrich Neumann examines some of the major US market access trends of the past few years, including…
Brazil / Pharma Market Outperforming LatAm, Vaccine Developments, Bolsonaro’s Political Standing
The Brazilian pharma market outperformed the Latin American average in Q1 of 2020 with a growth of 8.2 percent in…
Canada / Federal Consultations on a National Strategy for Rare Disease Drugs
Writing in the March edition of DIA’s Global Forum magazine, Judith Glennie examines the findings of Health…
USA / 2 Things the Biden Administration can do Now to Lower Costs at the Pharmacy
PhRMA’s Stephen J. Ubl outlines two ways in which the new US presidency can help lower healthcare costs and why…
In Conversation
Joe Lewis – Managing Director, Life Sciences Supply Chain Practice, Deloitte, USA
Joe Lewis outlines the key concerns of Deloitte’s pharma clients around manufacturing and supply chain operations in the wake of the COVID-19 pandemic, how companies can come out of the crisis stronger, and highlights some of the major issues surrounding vaccine allocation and deployment. One of the most common questions we received from clients is, who responded the best…
Latest Reports
Focus on Mexico
Mexico Pharma News: Bayer Targets Cancer; Novartis Gets…
The latest news from Mexican pharma, including Bayer’s big bet on oncology and…
Mexico-US Vaccine Tourism: Closed Borders, Fear of Fakes…
While Mexico struggles with its COVID-19 vaccination campaign, residents of the…
Read more from Mexico >>
Focus on Puerto Rico
New Puerto Rico Pharma Report January 2020 Out Now
Puerto Rico had to rebuild itself – in many cases quite literally – after…
Company Spotlight: Puerto Rico’s Quality &…
When life sciences companies decide to transfer the production of new drug to…
Read more from Puerto Rico >>
Focus on Colombia
Colombian Tecnoquimicas’ USD 200 Million Manufacturing…
Tecnoquimicas (TQ), the largest domestic player in Colombia’s USD 4.6 billion…
Colombia: The Great Indian Investment Wave
With the onset of universal public healthcare, new types of foreign actors have…
Read more from Colombia >>
Focus on Canada
Canada: Federal Consultations on a National Strategy for…
Writing in the March edition of DIA’s Global Forum magazine, Judith Glennie…
The Evolution of Medical Cannabis Legislation in Canada
Clint Sharples, CEO of Heritage Cannabis, gives a potted history of the medical…
Read more from Canada >>
Focus on Brazil
Brazil’s Largest Private Pharma Company Under Threat
Founded in 1950, EMS is one of the top two domestic pharma companies in Brazil.…
Brazilian Pharma: Market Outperforming LatAm, Vaccine…
The Brazilian pharma market outperformed the Latin American average in Q1 of…
Read more from Brazil >>
Focus on USA
Impact of COVID-19 on US Clinical Studies Conducted by…
Writing in the June edition of DIA’s Global Forum magazine, representatives of…
US Generics & Biosimilars: Five Takeaways from Access!…
Dan Leonard of the Association for Accessible Medicines (AAM) highlights five…
Read more from USA >>
Hot Topics / Mexican Pharma
Earlier in 2020, PharmaBoardroom sat down with several key stakeholders in the Mexican healthcare and life sciences…
LATAM / Colombian Tecnoquimicas’ USD 200 Million Manufacturing Investment
Tecnoquimicas (TQ), the largest domestic player in Colombia’s USD 4.6 billion pharma market, announced a swathe…
Research Partnerships / Novartis Teams Up to Tackle Neglected Diseases in Brazil
Swiss pharma giant Novartis is teaming up with the Oswaldo Cruz Foundation (Fiocruz) in Brazil to conduct research…
Talent / Pharma Leadership Strategies for Brazil
Three seasoned pharma executives with a wealth of experience working in Brazil offer their insights on leadership…
News Roundup / Mexican Pharma: February 2020
Below is a selection of top recent news from Mexican pharma and healthcare, including the healthcare reforms…
Brazil / Country's Largest Private Pharma Company Under Threat
Founded in 1950, EMS is one of the top two domestic pharma companies in Brazil. As a key player in the largest and…